A Specialized Diet for Multiple Sclerosis
FLAMEMS
A Flavonoid-enriched Mediterranean Diet for Multiple Sclerosis
1 other identifier
interventional
100
1 country
1
Brief Summary
This study examines the impact of a Mediterranean diet on individuals with multiple sclerosis (MS). MS is a multifactorial disease in which environmental factors, such as nutrition, can influence disease progression. Therefore, this study aims to investigate whether a healthier dietary pattern, specifically a flavonoid-rich Mediterranean diet, can affect disease parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable multiple-sclerosis
Started Apr 2023
Longer than P75 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2023
CompletedFirst Submitted
Initial submission to the registry
April 24, 2025
CompletedFirst Posted
Study publicly available on registry
June 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
June 24, 2025
April 1, 2025
5.7 years
April 24, 2025
June 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Microbiota changes
Microbiota sequencing on fecal samples to identify the different bacterial strains that are present.
Three timepoints, before start of the strict diet (day 14), after the strict diet (day 31), and after the follow-up period of three months (day 122).
Study Arms (1)
Flavonoid-enriched Mediterranean Diet
EXPERIMENTALInterventions
A set of dietary guidelines describing an adjusted Mediterranean diet focusing on the intake of flavonoid-rich products.
Eligibility Criteria
You may qualify if:
- Expanded Disability Status Scale (EDSS): 0-6
You may not qualify if:
- Diagnosed digestive pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jerome J. A. Hendrikslead
- Revalidatie & MS Centrum Overpeltcollaborator
Study Sites (1)
Hasselt University
Diepenbeek, Limburg, 3590, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. Dr. Jerome J.A. Hendriks
Study Record Dates
First Submitted
April 24, 2025
First Posted
June 24, 2025
Study Start
April 4, 2023
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
June 24, 2025
Record last verified: 2025-04